Proactive Investors - Run By Investors For Investors

Zoono Group finding a 'new and different space' for antibacterial products globally

Zoono Group Ltd (ASX:ZNO) managing director & CEO Paul Hyslop introduces Proactive Investors to the global biotech player in long-lasting antibacterials. The company's technology is designed for use on skin, fabric, and hard surfaces.

Zoono currently has a range of more than 14 consumer products with more in the pipeline; and a number of recently-announced international distribution deals with more under negotiation.

Hyslop says, "We are heading towards substantial revenues in the coming 12 to 24 months."

Meet Xanadu Mines Ltd, Invitrocue Ltd, Infinity Lithium Corporation Ltd, Oventus Medical Ltd and Zelda Therapeutics Ltd at our event, Melbourne , 14 May 2019. Register here »
View full ZNO profile View Profile

Zoono Group Ltd Timeline

© Proactive Investors 2019

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use